Palatin Technologies
PTN
#10076
Rank
โ‚ฌ22.16 M
Marketcap
13,02ย โ‚ฌ
Share price
-9.91%
Change (1 day)
1,300.14%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -โ‚ฌ4.7 Million

According to Palatin Technologies's latest financial reports the company's current earnings are โ‚ฌ8.84 Million. In 2024 the company made an earning of -โ‚ฌ22.83 Million, an increase over its 2023 earnings that were of -โ‚ฌ27.48 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ4.7 Million-79.45%
2024 -โ‚ฌ22.83 Million-16.9%
2023 -โ‚ฌ27.48 Million5.99%
2022 -โ‚ฌ25.93 Million-13.7%
2021 -โ‚ฌ30.04 Million33.25%
2020 -โ‚ฌ22.55 Million-172.11%
2019 โ‚ฌ31.25 M2352.33%
2018 โ‚ฌ1.27 M-94.13%
2017 โ‚ฌ21.72 M-154.92%
2016 -โ‚ฌ39.55 Million3.67%
2015 -โ‚ฌ38.15 Million878%
2014 -โ‚ฌ3.91 Million-72.64%
2013 -โ‚ฌ14.26 Million-33.11%
2012 -โ‚ฌ21.32 Million77.71%
2011 -โ‚ฌ12 Million
2003 -โ‚ฌ20.31 Million29.93%
2002 -โ‚ฌ15.63 Million36.18%
2001 -โ‚ฌ11.48 Million
1999 -โ‚ฌ9.53 Million6.04%
1998 -โ‚ฌ8.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MediciNova
MNOV
-โ‚ฌ10.18 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-โ‚ฌ24.99 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ0.49 B-12,262.47%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚ฌ42.84 M-1,154.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ56.6 M-1,492.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚ฌ99.72 Million 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ27.45 B-675,709.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚ฌ47.08 Million 1,058.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ11.09 B-273,088.15%๐Ÿ‡ฌ๐Ÿ‡ง UK